Clopidogrel

• Description:

  Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.

• Product Name Alternative:

  Clopidogrelum

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  P2Y Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/clopidogrel.html

• Concentration:

  10mM

• Purity:

  99.57

• Solubility:

  DMSO : 50 mg/mL (ultrasonic)

• Smiles:

  ClC1=C(C=CC=C1)[C@H](N2CCC3=C(C2)C=CS3)C(OC)=O

• Molecular Formula:

  C16H16ClNO2S

• Molecular Weight:

  321.82

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan.|[2]An insight into the interaction between clopidogrel and proton pump inhibitors By Shah, Bhavik S.; Parmar, Sanjay A.; Mahajan, Shailaja; Mehta, Anita A. From Current Drug Metabolism (2012), 13 (2),225-235.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, stored under nitrogen, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• Isoform:

  P2Y12 Receptor

• Citation 01:

  ACS Environ Au. 2025 Aug 8.|ACS Nano. 2023 Apr 11;17 (7) :6519-6533.|Biochem Pharmacol. 2025 Dec;242 (Pt 3) :117379.|Drug Des Devel Ther. 2020 Dec 21:14:5599-5610.|Front Pharmacol. 2022 Jan 10;12:792263.|Front Pharmacol. 2024 Oct 23:15:1496639.|Int J Biol Sci. 2019 Jan 1;15 (1) :239-252.|Int J Mol Med. 2025 May;55 (5) :78.|Int J Mol Sci. 2022 Aug 14;23 (16) :9118.|iScience. 2024 Feb 5;27 (3) :109134.|J Adv Res. 2024 Jul 5:S2090-1232 (24) 00269-8.|J Appl Physiol (1985) . 2021 Nov 1;131 (5) :1552-1564.|J Pharm Health Care Sci. 2021 May 4;7 (1) :18.|Open Chem. 2020 Jun.|Res Sq. 2023 Nov 14:rs.3.rs-3474507.|Theranostics. 2023 Mar 27;13 (6) :2040-2056.|Thromb J. 2024 Jul 10;22 (1) :59.|Thromb Res. 2023 Jul:227:17-24.|Thromb Res. 2024 Apr 16.|University of Colorado Denver. 2024.|ACS Omega. 2020 Aug 4;5 (32) :19995-20003.|Am J Transl Res. 2020 May 15;12 (5) :1741-1753.|Foods. 2023 Feb 10;12 (4) :777.|Front Pharmacol. 2021 Oct 8:12:734603.|J Ethnopharmacol. 2024 Aug 22:118707.|J Food Biochem. 2020 Sep;44 (9) :e13352.

• CAS Number:

  113665-84-2